Endocrinology, Vol 134, 287-292, Copyright © 1994 by Endocrine Society

ARTICLES

Progestin-induced growth hormone excess in the dog originates in the mammary gland

PJ Selman, JA Mol, GR Rutteman, E van Garderen and A Rijnberk
Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

In the dog endogenous progesterone and synthetic progestins may incite overproduction of GH, resulting in acromegaly and insulin resistance. This progrestin-induced excessive GH secretion is characterized by disappearance of the pulsatile secretion pattern and insensitivity to both stimulation with GHRH and inhibition with a somatostatin analog. This progestin-induced GH hypersecretion is not associated with neoplastic transformation at the pituitary level. These observations were the impetus for a search of a possible extrapituitary site of GH production. In four ovariohysterectomized dogs elevated plasma GH levels (46.5 +/- 7.7 micrograms/liter; mean +/- SEM) were induced by administration of synthetic progestins. In these dogs hypophysectomy did not led to a significant decrease in plasma GH levels. Analysis of the GH content of various tissue homogenates revealed that the highest GH immunoreactivity was found in extracts of the mammary gland. Ectopic production of GH in the mammary gland was confirmed by lowering of plasma GH concentration to values within the reference range within 2 h after complete mammectomy in two dogs with progestin-induced elevations of plasma GH levels. In one of these dogs the arterial and elevations of plasma GH levels. In one of these dogs the arterial and venous GH concentrations across the mammary gland were measured and an arterio- venous GH gradient was demonstrated. Displacement studies in the RIA and analysis by reversed-phase HPLC revealed that mammary-derived GH is highly similar to pituitary-derived GH. Immuno-histochemical staining revealed that GH immunoreactivity was localized in focal areas of hyperplastic ductular epithelium. In mammary tissue of healthy untreated female dogs no GH immunoreactivity was found. It is concluded that treatment of dogs with synthetic progestins can induce the overproduction of GH in the mammary gland. This GH is biologically active, highly similar to pituitary derived GH, and originates from foci of hyperplastic ductular epithelium of the mammary gland.

This article has been cited by other articles:

				J. Martin de las Mulas, J. Ordas, M. Y. Millan, A. Espinosa de los Monteros, and C. Reymundo Spontaneous Basaloid Adenomas of the Mammary Gland in Four Dogs: Clinicopathologic and Immunohistochemical Features Vet. Pathol., November 1, 2002; 39(6): 739 - 743. [Abstract] [Full Text] [PDF]

				M.C. Lacroix, P. Bolifraud, D. Durieux, A. Pauloin, M. Vidaud, and G. Kann Placental Growth Hormone and Lactogen Production by Perifused Ovine Placental Explants: Regulation by Growth Hormone-Releasing Hormone and Glucose Biol Reprod, March 1, 2002; 66(3): 555 - 561. [Abstract] [Full Text] [PDF]

				C. C. Capen Overview of Structural and Functional Lesions in Endocrine Organs of Animals Toxicol Pathol, January 1, 2001; 29(1): 8 - 33. [Abstract] [PDF]

				E. van Garderen, H. J. A. van der Poel, J. F. Swennenhuis, E. H. J. Wissink, G. R. Rutteman, E. Hellmén, J. A. Mol, and J. A. Schalken Expression and Molecular Characterization of the Growth Hormone Receptor in Canine Mammary Tissue and Mammary Tumors Endocrinology, December 1, 1999; 140(12): 5907 - 5914. [Abstract] [Full Text]

				P. Laroque, S. Molon-Noblot, S. Prahalada, L. G. Stabinski, C.-M. Hoe, C. P. Peter, P. Duprat, and M. J. van Zwieten Morphological Changes in the Pituitary Gland of Dogs Chronically Exposed to Exogenous Growth Hormone Toxicol Pathol, March 1, 1998; 26(2): 201 - 206. [Abstract] [PDF]